ArticleBritish journal of pharmacology2014

An in vivo role for Rho kinase activation in the tumour vascular disrupting activity of combretastatin A-4 3-O-phosphate.

L J Williams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.